Scientific Publications


Evaluation of cost-effectiveness of adjuvant osimertinib in patients with resected EGFR mutation-positive non-small cell lung cancer

PharmacoEconomics - Open
Verhoek A et al

Challenges to using big data in cancer

Cancer Research
Sweeney SM et al

Case studies for overcoming challenges in using big data in cancer

Cancer Research
Sweeney SM et al

Incidence of SARS-CoV-2 and subsequent mortality in a multi-site cohort of patients with cancer in the CancerLinQ Discovery database

JCO Oncology Practice
Ray et al

Retrospective analysis of real‐world management of EGFR‐mutated advanced NSCLC, after first‐line EGFR‐TKI treatment: US treatment patterns, attrition,…

Drugs Real World Outcomes
Nieva J et al

Reaching beyond maximum grade: Progress and future directions for modernising the assessment and reporting of adverse events in haematological maligna…

The Lancet Haematology
Thanarajasingam G et al.

Cancer registry data linkage of electronic health record data from ASCO’s CancerLinQ: Evaluation of advantages, limitations, and lessons learned

JCO Clinical Cancer Informatics
Charlton et al.

Real-world clinical outcomes of patients with BRCA-mutated, human epidermal growth factor receptor 2 (HER2)-negative metastatic breast cancer: a Cance…

Breast Cancer Research and Treatment
Miller et al.

Quantitating and Assessing Interoperability Between Electronic Health Records

Journal of the American Medical Informatics Association
Bernstam et al.


Real-world treatment patterns and sequencing in patients with locally advanced or metastatic urothelial cancer in the US

2023 ASCO Genitourinary Cancers Symposium
Kearney M

Survival of patients with multiple myeloma diagnosed with second primary malignancies: An ASCO CancerLinQ analysis

2022 ASH Annual Meeting
Cooper JD

Secondary primary malignancies in adolescent and young adults with multiple myeloma: An ASCO CancerLinQ analysis

2022 ASH Annual Meeting
Gibson SJ

Racial disparities in newly diagnosed hematological malignancies in the United States during the COVID-19 pandemic, January 2020 to March 2021

2022 ASH Annual Meeting
Bhandari S

Real world treatment patterns of adjuvant endocrine therapy and ovarian suppression in premenopausal HR+/HER2+ breast cancer

2022 San Antonio Breast Cancer Symposium
Sukumar JS

Demographics, clinical characteristics, treatment patterns and clinical outcomes of patients with stages I-III resected NSCLC without known EGFR mutat…

2022 ESMO Congress
Altorki NK

Long term survival outcomes in NSCLC patients with targeted therapy and immunotherapy: An IASLC analysis of ASCO CancerLinQ Discovery data

2022 World Conference on Lung Cancer
Behera M et al

Disparities in timely treatment among lung cancer patients

ASCO 2022 Annual Meeting
Chhabra J

Diagnosed with advanced prostate cancer: A population-based cohort from national oncology practices

ASCO 2022 Annual Meeting
Kim SP